BONNEY MICHAEL W

Average Profitability
11.01%
Insider Buys Quantity
4
Insider Buys Sum
$865,926.40
Insider Sells Quantity
2
Insider Sells Sum
$7.05M

Insider Activity of BONNEY MICHAEL W

According to the SEC Form 4 filings, BONNEY MICHAEL W, being in a position of

  1. director at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30000 shares for $5.85M,
    over all time since 2015-05-12, has bought 8000 shares for $682,080, and sold 36448 shares for $7.05M.

The largest purchase of all time was on 2015-05-12 and amounted to 4000 shares of Alnylam Pharmaceuticals, Inc. for $448,640.

The largest sale of all time was on 2023-12-27 and amounted to 30000 shares of Alnylam Pharmaceuticals, Inc. for $5.85M.

Biography of BONNEY MICHAEL W

No biography is available at this moment.

2023-12-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0237%
$195.00$5.85M-13.45%
2023-08-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
6,448
0.005%
$185.38$1.2M-11.97%
2019-12-04PurchaseBristol-Myers Squibb Company
BMY
director
176
<0.0001%
$58.90$10,366+5.24%
2019-09-09PurchaseSarepta Therapeutics, Inc.
SRPT
director
2,000
0.0027%
$86.74$173,480+39.82%
2016-03-09PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
4,000
0.0046%
$58.36$233,440-4.87%
2015-05-12PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
4,000
0.0047%
$112.16$448,640-19.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.